<DOC>
	<DOCNO>NCT02704468</DOCNO>
	<brief_summary>Chronic kidney disease ( CKD ) patient high incidence coronary artery problem event renal transplantation . And remain major cause mortality . The major risk marker arterial stiffness . The cardio-ankle vascular index ( CAVI ) new index overall stiffness estimate risk atherosclerosis . Fibroblast growth factor 21 ( FGF-21 ) metabolic regulator play important role cardiac remodel elevate FGF-21 report coronary heart disease carotid artery plaque could biomarkers atherosclerosis disease Investigators aim study association CAVI FGF-21 relation various parameter contribute cardiovascular disease eg . homocysteine Echocardiogram finding traditional basic factor .</brief_summary>
	<brief_title>FGF21 Can Help Predicting Arterial Stiffness Measured Cardio-ankle Vascular Index Renal Transplant Patients</brief_title>
	<detailed_description>A total 90 participant underwent renal transplant include study . The following measure do laboratory data collect . CAVI , Ecchocariogram , Homocysteine , Hs-CRP , Carotid IMT , FGF-21 , Medication renal transplantation , incidence cardiovascular disease correlation categorical data do use Pearson 's correlation test multiple regression analysis .</detailed_description>
	<criteria>renal transplant patient patient 1 month contraindication CAVI current smoker eGFR &lt; 15 ml/min/173 cardiac arrthymia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>CAVI</keyword>
	<keyword>FGF-21</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>renal transplant</keyword>
</DOC>